NST Test Results: Reactive vs Non-Reactive Explained

An NST report often ends with one of two words: reactive or non-reactive. While the classification may look straightforward, interpreting an NST requires a closer look at the fetal heart rate tracing and the clinical context.

A reactive NST is generally reassuring, indicating that the fetal heart rate has shown appropriate accelerations during monitoring. A non-reactive NST means that enough qualifying accelerations were not observed. This does not automatically mean fetal distress, but it may call for continued monitoring or further clinical assessment.

To understand the complete NST test in pregnancy, including why it is done, how the procedure works, and what to expect, read our detailed guide to NST Test in Pregnancy

The non-stress test (NST) is commonly used as part of antenatal fetal surveillance to provide information about fetal wellbeing. Understanding the difference between reactive and non-reactive results helps clinicians interpret the findings and decide whether additional surveillance may be needed.

What Is an NST?

A non-stress test (NST) is a non-invasive method of fetal monitoring that records the fetal heart rate over a period of time, usually while observing fetal movement.

The test is based on the expected response of the fetal heart rate to movement. When the fetus moves, the heart rate will typically increase temporarily. These changes are called fetal heart rate accelerations and are an important feature of NST interpretation.

During an NST, clinicians assess:

• Baseline fetal heart rate

• Fetal heart rate variability

• Accelerations

• Decelerations

• Fetal movement and its relationship to heart rate changes

NSTs may be used when additional fetal surveillance is indicated because of maternal conditions, pregnancy complications, decreased fetal movement, post-term pregnancy, or other clinical considerations.Learn more about when an NST is done in pregnancy and why your doctor may recommend it

What Do NST Test Results Mean?

NST results are generally described as reactive or non-reactive.

A reactive NST means the fetal heart rate has demonstrated the required number of qualifying accelerations during the monitoring period. A non-reactive NST means sufficient qualifying accelerations were not observed.

Neither result should be treated as a diagnosis on its own. A reactive NST is reassuring at the time of testing, but it does not guarantee that fetal status will remain unchanged. A non-reactive NST does not automatically indicate fetal compromise. The complete tracing, gestational age, reason for surveillance, and maternal-fetal factors all matter.

Reactive vs Non-Reactive NST

A reactive NST demonstrates sufficient fetal heart rate accelerations and is generally reassuring. A non-reactive NST does not demonstrate enough qualifying accelerations and may require further clinical interpretation.

The classification is only one part of NST test interpretation.

Reactive vs Non-Reactive NST at a Glance

What Does a Reactive NST Mean?

A reactive NST indicates that the fetal heart rate has demonstrated sufficient accelerations during the monitoring period.

For pregnancies at or beyond 32 weeks, a commonly used criterion is at least two accelerations within 20 minutes, with each acceleration increasing the fetal heart rate by at least 15 beats per minute above baseline and lasting at least 15 seconds. This is commonly known as the 15 × 15 criterion.

These accelerations are reassuring because they reflect an appropriate fetal response and provide information about fetal autonomic function. A reactive NST does not mean that every part of the tracing is necessarily normal. Clinicians still assess baseline fetal heart rate, variability and any decelerations.

What Does a Non-Reactive NST Mean?

A non-reactive NST means that the tracing did not demonstrate enough qualifying fetal heart rate accelerations during the assessment period.

A non-reactive result does not necessarily mean that something is wrong. The fetus may be in a sleep cycle, gestational age may affect reactivity, or medications may influence fetal activity or heart rate patterns.

This is why a non-reactive NST should not simply be dismissed. The important question is not only whether the NST is non-reactive, but also why it is non-reactive and what the rest of the tracing shows.

Why Is an NST Non-Reactive?

Several factors can contribute to a non-reactive NST.

Fetal sleep

A fetus may be in a quiet sleep state during the initial monitoring period, resulting in fewer movements and associated accelerations.

Gestational age

Fetal heart rate reactivity changes as the fetal autonomic nervous system matures. Earlier gestational age can therefore influence NST results.

Maternal medications

Certain medications can affect fetal activity or heart rate patterns and may contribute to reduced reactivity.

Reduced fetal movement

If fetal activity is limited during the monitoring period, there may be fewer opportunities to observe fetal heart rate accelerations.

Maternal or fetal conditions

Maternal illness or conditions affecting fetal oxygenation can also influence the fetal heart rate tracing. Other features of the tracing become particularly important in these situations.

There is therefore no single explanation for every non-reactive NST.

How to Interpret NST Results

A reliable NST test interpretation goes beyond the final reactive or non-reactive classification. Clinicians generally review the fetal heart rate tracing as a whole.

Baseline fetal heart rate

The baseline is the average fetal heart rate over a defined period, excluding transient changes caused by accelerations and decelerations. A baseline of 110–160 beats per minute is generally considered normal.

Fetal heart rate variability

Fetal heart rate variability refers to fluctuations in the fetal heart rate around the baseline. Moderate variability, generally 6–25 beats per minute, is an important feature when assessing the fetal heart rate pattern.

Accelerations

Accelerations are temporary increases in fetal heart rate. Their number, duration and amplitude are particularly important when determining whether an NST meets reactive criteria.

Decelerations

Decelerations also need to be assessed. Their timing, duration and pattern can affect interpretation, even when accelerations are present.

Fetal movement

Fetal movement provides an important stimulus for assessing the fetal heart rate response. The relationship between movement and acceleration is one of the key principles behind NST monitoring.

For a step-by-step explanation of how an NST is performed, read our guide to NST test procedure and what to expect

What Happens After a Non-Reactive NST?

The next step depends on the reason for testing and the findings on the complete tracing.

If fetal sleep is suspected, monitoring may be continued to allow more time for fetal movement and heart rate accelerations to occur. The clinician may also review baseline heart rate, variability, accelerations, decelerations, fetal movement, and the duration and quality of the recording.

If the NST remains non-reactive, additional fetal surveillance may be considered. Depending on the clinical situation, this may include a biophysical profile (BPP) or another appropriate assessment.

A BPP combines NST findings with ultrasound assessment of fetal breathing movements, gross body movements, muscle tone, and amniotic fluid.

If you want to understand what a non-reactive result may mean and what can happen next, read What Happens If an NST Is Non-Reactive?

There is no single next step for every non-reactive NST. Gestational age, maternal health, fetal movement, the indication for surveillance, and other pregnancy-specific factors influence clinical decision-making.

Does a Non-Reactive NST Mean Something Is Wrong?

Not necessarily.

A non-reactive NST means sufficient qualifying accelerations were not observed during the monitoring period. It does not, by itself, diagnose fetal distress.

Fetal sleep, gestational age, medications, and reduced fetal activity can contribute to a non-reactive result. However, because reduced reactivity can also occur with fetal compromise, the result should be appropriately evaluated.

A non-reactive NST is therefore a finding that requires interpretation, not an automatic diagnosis of fetal distress.

The Role of Digital Fetal Monitoring

Fetal monitoring is becoming increasingly digital, with technologies that can help capture, store, and share fetal monitoring information.

Depending on the system and clinical workflow, digital NST monitoring can support:

• Fetal heart rate recording

• Fetal movement tracking

• Digital NST reports

• Data storage

• Report sharing between patients and clinicians

• Longitudinal review of monitoring records

For hospitals, maternity-care providers, and healthcare organizations, these capabilities can make fetal monitoring information easier to document and access across the care pathway.

Digital monitoring is not intended to replace clinical interpretation. It can make data easier to capture, review, and share, while trained healthcare professionals remain responsible for interpreting findings within the appropriate clinical context.

Frequently Asked Questions About NST Test Results

1. What does a reactive NST mean?

A reactive NST means the fetal heart rate shows sufficient qualifying accelerations during monitoring. It is generally considered reassuring at the time of testing.

2. What does a non-reactive NST mean?

A non-reactive NST means sufficient qualifying fetal heart rate accelerations were not observed. It does not automatically indicate fetal distress and may require further assessment.

3. What is the difference between reactive and non-reactive NST?

A reactive NST demonstrates sufficient fetal heart rate accelerations, while a non-reactive NST does not. The complete tracing and clinical context are important for interpretation.

4. What is considered a normal NST result?

A reactive NST is generally considered a reassuring result, although clinicians also assess baseline heart rate, variability, decelerations, and other features of the tracing.

5. What happens if an NST is non-reactive?

Monitoring may be extended to allow for fetal activity or a sleep cycle to change. If it remains non-reactive, additional fetal surveillance may be considered depending on the clinical situation.

6. Does a non-reactive NST mean something is wrong?

Not necessarily. Fetal sleep, gestational age, and medications can contribute to a non-reactive result, although further evaluation may be needed to rule out fetal compromise.

Key Takeaways

• A reactive NST is generally reassuring, while a non-reactive result requires further clinical interpretation.

• A non-reactive NST does not automatically mean fetal distress; several temporary or clinical factors can affect reactivity.

• NST interpretation should consider the entire fetal heart rate tracing, including baseline, variability, accelerations, decelerations, and fetal movement.

• If an NST remains non-reactive, additional fetal surveillance may be considered based on the clinical situation.

Make Every NST Easier to Monitor

From capturing fetal heart rate to reviewing NST reports, a smoother monitoring workflow can make a difference in everyday maternity care.

Keyar DT Max brings fetal heart rate monitoring and digital reporting together, helping healthcare professionals monitor, record, and share NST data with greater ease.

Discover Keyar DT Max and take a more connected approach to fetal monitoring.

For a complete overview of the NST test, including the procedure, results, duration, cost, and what to expect, read our NST Test in Pregnancy guide

Conclusion

Understanding NST test results requires more than looking at whether a tracing is reactive or non-reactive. A reactive NST is generally reassuring, while a non-reactive NST indicates that sufficient fetal heart rate accelerations were not observed and may require further evaluation.

Gestational age, fetal movement, baseline heart rate, variability, and decelerations all contribute to interpretation. Ultimately, the NST result should be considered alongside the broader maternal and fetal clinical picture to guide appropriate surveillance and care.